期刊文献+

克拉屈滨的合成工艺改进及其主要杂质研究 被引量:2

Improved synthesis of cladribine and research on its major impurity
原文传递
导出
摘要 目的:改进克拉屈滨的合成工艺,控制生成的主要杂质,提高收率与质量,获得良好的生产工艺。方法:以2-氯-6氨基嘌呤和2-脱氧-D-核糖为原料,对6步反应条件进行优化与改进,合成克拉屈滨,对克拉屈滨的主要杂质进行鉴别,研究其产生原因与控制方法。结果:产品质量及收率得到提高,质量符合USP35标准,收率达到30.2%,主要杂质的结构经MS,1HNMR,13CNMR确证为嘌呤二聚体核苷类似物。结论:优化后工艺收率高,产品质量好,操作简便,适合工业化生产。 Objective: To improve the synthesis of cladribine and investigate its major impurity. Methods:After the conditions of six-step process had been optimized and modified,cladribine was synthesized from 2-chloroadenine and 2-deoxy-D-ribose,and the major impurity of cladribine was studied. Results: The quality and yield of cladribine were improved. The quality met USP35 specifications,and the yield was up to 30. 2%. The major impurity was analogues of purine nucleoside dimmers,and the structure was identified by MS,1HNMR and13 CNMR. Conclusion: The improved process is easy to operate with high yield and quality,and suitable for industrial production.
出处 《中国新药杂志》 CAS CSCD 北大核心 2015年第5期565-569,575,共6页 Chinese Journal of New Drugs
基金 湖北省自然科学基金计划重点项目(创新群体)(2013CFA015)
关键词 克拉屈滨 合成 工艺改进 杂质 嘌呤二聚体核苷类似物 控制 cladribine synthesis process improvement impurity purine dimers nucleoside analogues control
  • 相关文献

参考文献2

二级参考文献12

  • 1费嘉,茅宁莹.国际新药研发的新动向及对我国医药产业的启示[J].中国新药杂志,2005,14(9):1093-1097. 被引量:3
  • 2吴海霞,李野,赵双春.浅析新药研发项目的六大风险[J].中国新药杂志,2006,15(24):2092-2094. 被引量:18
  • 3Ikehara M, Tada H. A new type of "cyclonucleoside" derived from 2-chloro-8-mercapto-9-β-D-xylofuranosyladenine [J].J Am Chem Soc, 1963, 85 (15): 2344-2345.
  • 4Ikehara M, Tada H. Studies of nucleosides and nucleotides.ⅩⅩⅣ. Purine cyclonucleosides. I. 8,2'-cyclonucleoside derived from 2-chloro-8-mercapto-9-β-D-xylofuranosyladenine [J].JAm Chem Soc, 1965, 87 (3): 606-610.
  • 5Christensen LF, Broom AD. Synthesis and biological activity of selected 2,6-disubstituted- (2-deoxy-α- and -β-D-erythropentofuranosyl) purines [J]. J Med Chem, 1972, 15 (7): 735-739.
  • 6Kazimierczuk Z, Cottam HB, Revankar GR, et al. Synthesis of 2'-deoxytubercidin, 2'-deoxyadenosine, and related 2'-deoxynucleosides via a novel direct stereospecific sodium salt glycosylation procedure [J]. J Am Chem Soc, 1984, 106(21): 6379-6382.
  • 7Gerszberg S, Alonso D. Method for the production of 2-chloro-2'-deoxyadenosine (cladribine) and its 3,5-di-O-p-toluoyl-derivative[P]. US: 2002052491, 2002-05-02.
  • 8Rolland V, Kotera M, Lhomme J. Convenient preparation of 2-deoxy-3,5-di-O-p-toluoyl-α-D-erythro-pentofuranosyl chloride[J]. Synth Commun, 1997, 27 (20): 3505-3511.
  • 9上海情报服务平台.数据看点:欧美制药研发投入持续增长[EB/OL].[2007-07-11].http://www.istis.sh.cn/list/list_n.asp?id=3154&st=N.
  • 10Burrill & Company. Analysis for PhRMA. Pharmaceutical industry profile 2006[M ]. Washington, DC : Burrill & Company,2006:2.

共引文献9

同被引文献7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部